Your Health. Your Family. Your Choice.
|History of Changes from the VAERS Wayback Machine|
|Vaccination / Manufacturer||Lot / Dose||Site / Route|
|COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH||EX3617 / 2||- / -|
Administered by: Other Purchased by: ??
Symptoms: Blood pressure systolic increased, Body temperature, Cold sweat, Dyspnoea, Heart rate, Heart rate decreased, Oxygen saturation, Palpitations, Rash, Hyporesponsive to stimuli, Blood pressure measurement
Life Threatening? No
Birth Defect? No
Permanent Disability? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Diagnostic Lab Data: Test Date: 20210604; Test Name: Blood pressure; Result Unstructured Data: Test Result:140-90; Comments: 2 minutes after the vaccination; Test Date: 20210604; Test Name: Blood pressure; Result Unstructured Data: Test Result:118-70; Comments: 10 minutes after the administration of drugs; Test Date: 20210604; Test Name: Body temperature; Result Unstructured Data: Test Result:36.7 Centigrade; Comments: Before vaccination; Test Date: 20210604; Test Name: Heart rate; Result Unstructured Data: Test Result:45; Comments: 2 minutes after the vaccination; Test Date: 20210604; Test Name: Heart rate; Result Unstructured Data: Test Result:47; Comments: 10 minutes after the administration of drugs; Test Date: 20210604; Test Name: Oxygen saturation; Test Result: 98 %; Comments: 2 minutes after the vaccination; Test Date: 20210604; Test Name: Oxygen saturation; Test Result: 99 %; Comments: 10 minutes after the administration of drugs
CDC 'Split Type': JPPFIZER INC2021658633
Write-up: reacion to question was dull; cold sweat; Pulse rate low (45); dyspnoea; palpitations; rash on the chest; rash on the chest; blood pressure was 140-90; This is a spontaneous report from a contactable physician received from a regulatory authority. Regulatory authority report number is v21111851. The patient was a 40-year-old female. Body temperature before vaccination was 36.7 degrees Centigrade. There were no points to be considered on the vaccine screening questionnaire (primary diseases, allergies, vaccinations and illnesses within the last one month, medications the patient was taking, past adverse effect history, growth status). On an unspecified date, the patient previously received the first dose of bnt162b2 (COMIRNATY, Lot# EX3617, Expiration date 31Aug2021). On 04Jun2021, at 13:20 (the day of vaccination), the patient received the second dose of bnt162b2 (COMIRNATY, Solution for injection, Lot number EX3617, Expiration date 31Aug2021) via an unspecified route of administration as a single dose for COVID-19 immunization. Event onset date was reported as 04Jun2021, at 13:25 (5 minutes after the vaccination). On 04Jun2021 (the day of vaccination), the outcome of the event was recovered. The course of the event was as follows: On 04Jun2021, at 13:22 (2 minutes after the vaccination), the patient experienced cold sweat, palpitations, dyspnoea, and rash on the chest. The blood pressure was 140-90. Heart rate was 45. Oxygen saturation was 98%. The patient could answer questions when being asked. But the reaction was dull. BICANATE was administered via intravenous drip. Adrenaline was administered via injection. After 10 minutes, the symptoms almost disappeared. The blood pressure was 118-70. Heart rate was 47. Oxygen saturation was 99%. The reporting physician classified the event as non-serious and assessed that the event was related to bnt162b2. There was no other possible cause of the event such as any other diseases.
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166